Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More
Natasha Mason and Zeus Tipado will be presenting at ICPR 2024 in Haarlem, Netherlands this June!
Maastricht Psychedelic Symposium
On May 24, the Maastricht Psychedelic Research Team will organize a mini-symposium on psychedelics. We will welcome two international speakers: Prof. dos Santos and Prof. Bouso from Brazil and Spain to discuss their ayahuasca and ibogaine research. We also have several internal speakers: presenting on mystical vs. autobiographical psychedelic experiences (Dr Kangaslampi), microdosing (Ms. Haijen), and 5-MeO-DMT (Mr. Reckweg). All students and staff with an interest in this topic are welcome to join us in the Maastrichtzaal in UNS40 between 13:30-15:30.
If you can’t make it, a live stream will be available at the link below!
Read about our new paper on the neurological origins of a visual psychedelic hallucination
Congratulations to Zeus Tipado on his newly published paper that introduces a new theory as to why a person experiences a visual trip on psychedelics.
Read The PaperParticipate in our studies!
We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.
View All Studies
Our Scientists
Aedan O’Shea, MSc
I have a long standing interest in unravelling the therapeutic mechanisms of Psychedelics, and in this project I will investigate the effect of Psychedelic drug exposure in humans on miRNA’s transported in neuron-derived Extracellular Vesicles...
Dr. Lilian Kloft
False Memory, Cognition, Drugs
I am a postdoctoral researcher in the fields of psychopharmacology and forensic psychology with an international education from various high-class universities.
Dr. C. Rob Markus
I became an expert on the relation between stress, brain (gene) vulnerability and the development of cognitive-affective complaints/disorders as well as in testing (claims about) dietary treatment/assessment methods.
Dr. Malin Vedøy Uthaug
Ayahuasca, 5-MeO-DMT, Consciousness
I am an altered states of consciousness researcher from Norway and one of the world leading experts on 5-MeO-DMT.
Dr. Rudy Schreiber
CNS Drug Discovery, Research Domain Criteria
I started my career in central nervous system drug discovery in 1993 and subsequently progressed from bench scientist to senior leadership roles at global pharmaceutical companies
Katharina Lege, MSc
Cannabinoids, Neuroimaging, Consciousness
Coming from a background of psychology and clinical neuroscience, I developed a strong interest in altered states of the mind as in mediation or yoga practices.
Pablo Mallaroni, MSc
Psychedelics, fMRI/MRS, Idiosyncracy
I am PhD candidate with the Psychopharmacology Unit of Maastricht University with a background in translational neuroscience.
Dr. Conny Quaedflieg
Stress Resilience, Intentional Forgetting, EEG
Through my extensive research experience, I have built expertise in various disciplines (psychology, psychophysiology, neurosciences) and I have become enthusiastic about bridging them.
Giordano Rossi, MSc
Esketamine, Depression, Ayahuasca
We are also evaluating subjective effects, safety, tolerability, and possible changes in personality, social cognition and well-being.
Psychedelic Research
Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers
→
Microdosing with psychedelics to self-medicate for ADHD symptoms in adults: A prospective naturalistic study
→
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life
5-MeO-DMT, naturalistic, psychopathological
→
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
→
Cannabis Research
Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans
→
Intoxication by a synthetic cannabinoid (JWH-018) causes cognitive and psychomotor impairment in recreational cannabis users
Cognition, Psychomotor, Cannabis
→
Get in Touch
We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.